Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lynn Katsoulis"'
Autor:
Klaus Reither, Lynn Katsoulis, Trevor Beattie, Nicolene Gardiner, Nicole Lenz, Khadija Said, Elirehema Mfinanga, Christian Pohl, Katherine L Fielding, Hannah Jeffery, Benjamin M Kagina, Elisabeth J Hughes, Thomas J Scriba, Willem A Hanekom, Søren T Hoff, Peter Bang, Ingrid Kromann, Claudia Daubenberger, Peter Andersen, Gavin J Churchyard
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e114602 (2014)
BACKGROUND:Novel tuberculosis vaccines should be safe, immunogenic, and effective in various population groups, including HIV-infected individuals. In this phase II multi-centre, double-blind, placebo-controlled trial, the safety and immunogenicity o
Externí odkaz:
https://doaj.org/article/0fa462a1af29461caae572c251527dda
Autor:
Hannah Jeffery, Katherine Fielding, Søren T. Hoff, Benjamin M. Kagina, Peter Andersen, Elirehema Mfinanga, Nicole Lenz, Klaus Reither, Elisabeth J. Hughes, Lynn Katsoulis, Claudia Daubenberger, Christian Pohl, Nicolene Gardiner, Trevor Beattie, Willem A. Hanekom, Khadija Said, Gavin J. Churchyard, Ingrid Kromann, Thomas J. Scriba, Peter Bang
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e114602 (2014)
PLoS ONE
PLoS ONE
BACKGROUND: Novel tuberculosis vaccines should be safe, immunogenic, and effective in various population groups, including HIV-infected individuals. In this phase II multi-centre, double-blind, placebo-controlled trial, the safety and immunogenicity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c96ede20070f1f03067d4a00d9a88db
https://researchonline.lshtm.ac.uk/id/eprint/2030874/1/pone.0114602.pdf
https://researchonline.lshtm.ac.uk/id/eprint/2030874/1/pone.0114602.pdf
Autor:
Siegfried E. Drewes, Xolani K. Peter, Fatima Khan, Ronette Gehring, Orde Q. Munro, Rod M Mackenzie, Fanie R. van Heerden, Lynn Katsoulis
Publikováno v:
Phytochemistry. 65:1117-1121
From the aqueous extract of the dry rhizomes of Gunnera perpensa the minor components pyrogallol, succinic acid, lactic acid, and the trimethyl ether of ellagic acid glucoside were isolated. The major constituent was identified as Z-venusol, a phenyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e86e56ffeb533914c240227cf0cc6198
https://doi.org/10.1016/j.phytochem.2004.02.024
https://doi.org/10.1016/j.phytochem.2004.02.024
The globalization of clinical trials and the growth of research in HIV/AIDS, tuberculosis, and malaria have resulted in the emergence of clinical trial sites throughout Africa. The number of patients recruited in Africa into pivotal trials supporting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::591f9122edfe005c2d674dbf6ee1e9e4
https://doi.org/10.1016/b978-0-12-415787-3.00003-5
https://doi.org/10.1016/b978-0-12-415787-3.00003-5
Autor:
Yaw Asare-Aboagye, Mehtap Asenaoktar, Serdar Asenaoktar, Menghis Bairu, Lesley Burgess, Herng-Der Chern, Havana Chikoto, Richard Chin, James (Dachao) Fan, Suzanne Gagnon, Don Hayward, Jakub Hort, Ankit Joshi, Lynn Katsoulis, Elizabeth Messersmith, Bogdan O. Popescu, Philip Scheltens, Peter Schueler, Victor Strugo, Quintin Van Wyk, Nermeen Varawalla, Dong Wei, Janice B. Wilson, Zhijie Xia, Juncai (Jack) Xu, Jing Yin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8806b39f509aff84d136303918397821
https://doi.org/10.1016/b978-0-12-415787-3.01002-x
https://doi.org/10.1016/b978-0-12-415787-3.01002-x
The implementation of good clinical practice (GCP) guidelines has beneficial effects on the quality of clinical research. According to these standards, trial sites conducting Phase I–IV clinical trials must use documented systems of quality control
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad502f2be2c510c8cd72bdc8b3bcf3c9
https://doi.org/10.1016/b978-0-12-415787-3.00004-7
https://doi.org/10.1016/b978-0-12-415787-3.00004-7
Autor:
Sebastian Antonelli, Jennifer Aquino, Irina Baeumer, Sue Bailey, Menghis Bairu, Alin Balalau, Mary Bareilles, Havanakwavo Chikoto, Edwin Chia, Richard Chin, Mateusz Chrząszcz, Marianne Coetzee, Gillian Corken, Romillie E. Cruz, Victoria Datsenko, Jogin Desai, James (Dachao) Fan, Carlos Fernando de Oliveira, Janos Filakovszky, Suzanne Gagnon, Edda Gomez-Panzani, Antonio Guimaraes, Rajesh Jain, Jay Johnson, Lynn Katsoulis, Masanobu Kimura, Pavel Lebeslé, Barbara Lilienfeld, Monica Lizano, Anna Paula Más, Mohua Maulik, Vladimir Misik, Hiroshi Naito, Alan Ong, Mariano Parma, Viola-Marie Raubenheimer, Svetlana Riekstina, Mira Serhal, S.D. Seth, Surinder Singh, Tracy Southwood, Margaret Ann Snowden, Monika Stepniewska, Victor Strugo, Veronica Suarez, Krisztina Szabo, J. Rick Turner, Henrietta Ukwu, Sorika van Niekerk, Nermeen Varawalla, Daniel Vazquez, Johan Venter, Elizabeth Villeponteaux, Greg Voinov, Hiromi Wakita, Janice B. Wilson, Yaw Asare-Aboagye, Jenny Zhang, Yuriy Zuykov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::baba7883942b425186f57ac986eb102a
https://doi.org/10.1016/b978-0-12-381537-8.10028-7
https://doi.org/10.1016/b978-0-12-381537-8.10028-7
Publisher Summary This chapter discusses clinical trials in South Africa. The establishment of the Medicines Control Council (MCC) in 1965 and the country's first international symposium on drug development in 1972 both stimulated clinical research a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9e968dde1a6b6fb9c4360a4f6b62b97
https://doi.org/10.1016/b978-0-12-381537-8.10013-5
https://doi.org/10.1016/b978-0-12-381537-8.10013-5